Hepatocyte Growth Factor as a Prognostic Marker in Heart Failure: Promise and Challenges

Publisher： Karger

E-ISSN： 1421-9751|121|4|237-239

ISSN： 0008-6312

Source： Cardiology, Vol.121, Iss.4, 2012-05, pp. : 237-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Digoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?

By  

Cardiology, Vol. 134, Iss. 3, 2016-03 ,pp. : 311-319

Karger

Access to resources Recommend Favorite

Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia

By Zhelyazkova A. G.   Tonchev A. B.   Kolova P.   Ivanova L.   Gercheva L.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 6, 2008-10 ,pp. : 492-500

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Significance of Circulating Levels of Hepatocyte Growth Factor in Patients with Chagas’ Disease and Idiopathic Dilated Cardiomyopathy

By  

Cardiology, Vol. 121, Iss. 4, 2012-05 ,pp. : 240-246

Karger

Access to resources Recommend Favorite

Prognostic markers for acute heart failure

By Pascual-Figal Domingo A   Caballero Luis   Sanchez-Mas Jesús   Lax Antonio  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 4, 2013-07 ,pp. : 379-392

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Stratification of Acute Heart Failure

By  

Cardiology, Vol. 114, Iss. 1, 2009-04 ,pp. : 72-74

Karger

Access to resources Recommend Favorite